These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8302422)

  • 1. Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's disease).
    Chan TM; Cheng IK; Wong KL; Chan KW
    Nephron; 1993; 65(4):628-32. PubMed ID: 8302422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membranoproliferative glomerulonephritis associated with multicentric angiofollicular lymph node hyperplasia. Case report and review of the literature.
    Said R; Tarawneh M
    Am J Nephrol; 1992; 12(6):466-70. PubMed ID: 1292348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission of nephrotic syndrome after thalidomide therapy in a patient with Castleman's disease.
    Menegato MA; Canelles MF; Tonutti E; Pizzolitto S
    Clin Nephrol; 2004 May; 61(5):352-6. PubMed ID: 15182131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membranoproliferative glomerulonephritis in Castleman's disease: a systematic review of the literature and 2 case reports.
    Zhang H; Wang R; Wang H; Xu Y; Chen J
    Intern Med; 2012; 51(12):1537-42. PubMed ID: 22728487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of Castleman's disease complicated with nephrotic syndrome due to glomerulopathy mimicking membranoproliferative glomerulonephritis.
    Sugimoto T; Ito J; Takeda N; Gasyu I; Okazaki T; Sakaguchi M; Osawa N; Tanaka Y; Oka K; Uzu T; Kashiwagi A
    Am J Med Sci; 2008 Jun; 335(6):495-8. PubMed ID: 18552583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
    Seida A; Wada J; Morita Y; Baba M; Eguchi J; Nishimoto N; Okino T; Ichimura K; Yoshino T; Makino H
    Am J Kidney Dis; 2004 Jan; 43(1):E3-9. PubMed ID: 14712466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Castleman's disease and mesangial proliferative glomerulonephritis: the role of interleukin-6.
    Lui SL; Chan KW; Li FK; Cheng IK; Chan TM
    Nephron; 1998; 78(3):323-7. PubMed ID: 9546694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidly progressive renal failure associated with angiofollicular lymph node hyperplasia.
    Tsukamoto Y; Hanada N; Nomura Y; Hiki Y; Kasai K; Shigematsu H; Kobayashi Y
    Am J Nephrol; 1991; 11(5):430-6. PubMed ID: 1809043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease).
    Montoli A; Minola E; Stabile F; Grillo C; Radaelli L; Spanti D; Luccarelli E; Spata C; Minetti L
    Am J Nephrol; 1995; 15(2):142-6. PubMed ID: 7733151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
    Saiki R; Katayama K; Hirabayashi Y; Oda K; Fujimoto M; Murata T; Nakajima A; Dohi K
    BMC Nephrol; 2021 Jun; 22(1):216. PubMed ID: 34107915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of multicentric Castleman's disease with membranoproliferative glomerulonephritis type 3-like lesion.
    Nagai K; Usui J; Noguchi K; Unai K; Hiwatashi A; Arakawa Y; Togashi A; Morito N; Saito C; Yoh K; Tsuruoka S; Kojima H; Aita K; Nagata M; Yamagata K
    Pathol Int; 2011 Nov; 61(11):686-90. PubMed ID: 22029682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crescentic membranoproliferative glomerulonephritis and hypocomplementemic urticarial vasculitis.
    Enríquez R; Sirvent AE; Amorós F; Pérez M; Matarredona J; Reyes A
    J Nephrol; 2005; 18(3):318-22. PubMed ID: 16013022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions.
    Hashimoto K; Sano T; Honma Y; Ida M; Tominaga H; Sawada A; Abe T; Takahashi H; Shimada Y; Masaki T; Kamata M; Naito S; Aoyama T; Takeuchi Y; Akiya M; Inukai M; Nakata N
    CEN Case Rep; 2019 Feb; 8(1):48-54. PubMed ID: 30244358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.
    Lajoie G; Kumar S; Min KW; Silva FG
    Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of six kidney disease-associated Castleman's disease cases.
    Sui Y; Zhao D
    Clin Nephrol; 2015 Dec; 84(6):344-52. PubMed ID: 26445003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
    Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
    Ito S; Kuriyama H; Iino N; Iguchi S; Shimada H; Ueno M; Narita I; Nakano M; Nishi S; Karasawa R; Gejyo F
    Clin Exp Nephrol; 2003 Dec; 7(4):290-5. PubMed ID: 14712359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
    Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T
    Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Membranoproliferative glomerulonephritis-like lesion with fibrillary deposition associated with multicentric Castleman's disease].
    Akimoto H; Shirai M; Usutani S; Masaoka H; Hidaka S; Kakuta S; Kawasugi K; Nagase M
    Nihon Jinzo Gakkai Shi; 1998 May; 40(4):301-8. PubMed ID: 9654915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal complications of Castleman's disease: report of two cases and analysis of 75 cases.
    Yuan XG; Hu W; Chen FF; Huang BF; Zhao XY
    Clin Exp Nephrol; 2011 Dec; 15(6):921-6. PubMed ID: 21822592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.